---
title: "Morgan Stanley Keeps Their Sell Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293242356.md"
description: "Morgan Stanley analyst Aisyah Noor maintained a Sell rating on Fresenius Medical Care AG & Co. KGaA, setting a price target of €32.00. This follows a similar Sell rating from Bank of America Securities's Anna Ractliffe issued today. In contrast, Citi maintained a Hold rating on the stock on July 17."
datetime: "2026-07-20T16:35:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293242356.md)
  - [en](https://longbridge.com/en/news/293242356.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293242356.md)
generator: "portal-rs"
---

# Morgan Stanley Keeps Their Sell Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)

Morgan Stanley analyst Aisyah Noor maintained a Sell rating on Fresenius Medical Care AG & Co. KGaA today and set a price target of €32.00.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

According to TipRanks, Noor is a 3-star analyst with an average return of 2.8% and a 43.10% success rate.

In addition to Morgan Stanley, Fresenius Medical Care AG & Co. KGaA also received a Sell from Bank of America Securities’s Anna Ractliffe in a report issued today. However, on July 17, Citi maintained a Hold rating on Fresenius Medical Care AG & Co. KGaA (LSE: 0H9X).

### Related Stocks

- [FME.DE](https://longbridge.com/en/quote/FME.DE.md)
- [FMS.US](https://longbridge.com/en/quote/FMS.US.md)
- [MS.US](https://longbridge.com/en/quote/MS.US.md)
- [BAC.US](https://longbridge.com/en/quote/BAC.US.md)
- [C.US](https://longbridge.com/en/quote/C.US.md)
- [MS-O.US](https://longbridge.com/en/quote/MS-O.US.md)
- [MS-Q.US](https://longbridge.com/en/quote/MS-Q.US.md)
- [MS-E.US](https://longbridge.com/en/quote/MS-E.US.md)
- [MS-I.US](https://longbridge.com/en/quote/MS-I.US.md)
- [MS-L.US](https://longbridge.com/en/quote/MS-L.US.md)
- [MS-P.US](https://longbridge.com/en/quote/MS-P.US.md)
- [MS-A.US](https://longbridge.com/en/quote/MS-A.US.md)
- [MS-F.US](https://longbridge.com/en/quote/MS-F.US.md)
- [MS-K.US](https://longbridge.com/en/quote/MS-K.US.md)
- [BAC-Q.US](https://longbridge.com/en/quote/BAC-Q.US.md)
- [BML-L.US](https://longbridge.com/en/quote/BML-L.US.md)
- [BAC-L.US](https://longbridge.com/en/quote/BAC-L.US.md)
- [BAC-K.US](https://longbridge.com/en/quote/BAC-K.US.md)
- [BML-H.US](https://longbridge.com/en/quote/BML-H.US.md)
- [BAC-N.US](https://longbridge.com/en/quote/BAC-N.US.md)
- [BAC-E.US](https://longbridge.com/en/quote/BAC-E.US.md)
- [MER-K.US](https://longbridge.com/en/quote/MER-K.US.md)
- [BAC-O.US](https://longbridge.com/en/quote/BAC-O.US.md)
- [BML-G.US](https://longbridge.com/en/quote/BML-G.US.md)
- [BAC-M.US](https://longbridge.com/en/quote/BAC-M.US.md)
- [BAC-B.US](https://longbridge.com/en/quote/BAC-B.US.md)
- [BML-J.US](https://longbridge.com/en/quote/BML-J.US.md)
- [BAC-S.US](https://longbridge.com/en/quote/BAC-S.US.md)
- [BAC-P.US](https://longbridge.com/en/quote/BAC-P.US.md)
- [8648.JP](https://longbridge.com/en/quote/8648.JP.md)
- [C-R.US](https://longbridge.com/en/quote/C-R.US.md)

## Related News & Research

- [FDA Slams Fresenius Over Leaking Dialysis Bags, Warns of Potentially Life-Threatening Risk](https://longbridge.com/en/news/298049849.md)
- [BlackRock trims Fresenius Medical Care voting rights to 6.52% from 6.63%](https://longbridge.com/en/news/298208525.md)
- [REG - T.Rowe Price Assoc BAWAG Group AG - Form 8.3 - Bawag Group AG](https://longbridge.com/en/news/298214027.md)
- [Fresenius Medical Care (XTRA:FME) Could Be 8% Undervalued On FDA Warning Letter](https://longbridge.com/en/news/298186885.md)
- [Positive Report for Arbonia AG (ARBN) from UBS](https://longbridge.com/en/news/298205707.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**